KAZIA THERAPEUTICS LIMITED - Announcements

0.00%

8.0¢

Currently unlisted.

Kazia Therapeutics Limited is an Australia-based oncology-focused drug development... Kazia Therapeutics Limited is an Australia-based oncology-focused drug development company. The Company is engaged in pharmaceutical research and development. The Company’s drug candidates are designed to treat diseases such as brain cancer, renal cancer, and liver cancer. The Company’s lead programs include paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of VEGFR3. EVT801 is being developed in patients with advanced cancer. EVT801 targets angiogenesis, the formation of new blood vessels around a tumor.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

KZA	Removal from Official List		15/11/23	87.34KB	Share
KZA	Change in substantial holding		14/11/23	1.51MB	Share
KZA	Suspension from Official List	PRICE SENSITIVE	13/11/23	86.69KB	Share
KZA	Change in substantial holding		08/11/23	1.59MB	Share
KZA	Notice of Annual General Meeting/Proxy Form		03/11/23	1.07MB	Share
KZA	Preliminary update from ongoing Phase 2 Study of Paxalisib		02/11/23	150.76KB	Share
KZA	Proposed issue of securities - KZA		31/10/23	24.89KB	Share
KZA	Kazia announces short term unsecured Promissory Note	PRICE SENSITIVE	31/10/23	169.34KB	Share
KZA	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	253.76KB	Share
KZA	Kazia SEC Form 20-F		27/10/23	630.23KB	Share
KZA	Kazia announces Clinical Data at ESMO 2023 from EVT801 Study		24/10/23	167.72KB	Share
KZA	Change in substantial holding		23/10/23	1.51MB	Share
KZA	Change of AGM date		16/10/23	127.98KB	Share
KZA	Shareholder communication on the ASX de-listing process	PRICE SENSITIVE	13/10/23	667.16KB	Share
KZA	Reinstatement to Official Quotation	PRICE SENSITIVE	11/10/23	408.79KB	Share
KZA	Kazia announces intention to voluntarily de-list from ASX	PRICE SENSITIVE	11/10/23	226.44KB	Share
KZA	Voluntary Suspension	PRICE SENSITIVE	10/10/23	299.26KB	Share
KZA	Trading Halt	PRICE SENSITIVE	06/10/23	1.03MB	Share
KZA	Presentations at upcoming scientific meetings		05/10/23	128.19KB	Share
KZA	Acceptance of late-breaking abstract of PNOC022 data	PRICE SENSITIVE	29/09/23	129.86KB	Share
KZA	Change in substantial holding		11/09/23	1.52MB	Share
KZA	2023 Corporate Governance Statement		31/08/23	219.65KB	Share
KZA	Appendix 4G		31/08/23	275.48KB	Share
KZA	Appendix 4E and 2023 Annual Report	PRICE SENSITIVE	31/08/23	6.51MB	Share
KZA	Final Director's Interest Notice - Iain Ross		11/08/23	231.26KB	Share
KZA	Cleansing Notice - updated		11/08/23	131.48KB	Share
KZA	Cleansing Notice		11/08/23	130.98KB	Share
KZA	Application for quotation of securities - KZA		11/08/23	26.63KB	Share
KZA	Kazia announces change to Board of Directors		11/08/23	125.76KB	Share
KZA	Appointment of Dr John Friend as Managing Director		01/08/23	272.73KB	Share
KZA	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	318.42KB	Share
KZA	Notification regarding unquoted securities - KZA		19/07/23	26.04KB	Share
KZA	Change in substantial holding		17/07/23	210.33KB	Share
KZA	Cleansing Notice		14/07/23	154.33KB	Share
KZA	Appendix 2A		14/07/23	177.14KB	Share
KZA	Proposed issue of securities - KZA		14/07/23	25.07KB	Share
KZA	Notification of cessation of securities - KZA		13/07/23	22.53KB	Share
KZA	Change in substantial holding		11/07/23	1.5MB	Share
KZA	Paxalisib receives Fast Track Designation from US FDA		07/07/23	183.55KB	Share
KZA	Kazia Corporate Update and Corporate Presentation		26/06/23	2.61MB	Share
KZA	Launch of LUMOS2 Study		08/06/23	163.17KB	Share
KZA	Constitution		07/06/23	493.48KB	Share
KZA	Appointment of Non-executive Director		05/06/23	278.65KB	Share
KZA	Kazia CEO participates in White House Cancer Moonshot Forum		26/05/23	138.12KB	Share
KZA	Cancel - Notification of cessation of securities - KZA		25/05/23	24.21KB	Share
KZA	Quarterly Activities/Appendix 4C Cash Flow Report - updated		09/05/23	410KB	Share
KZA	Notification regarding unquoted securities - KZA		08/05/23	29.85KB	Share
KZA	Notification of cessation of securities - KZA		05/05/23	24.66KB	Share
KZA	Final Director's Interest Notice - Dr J Garner		02/05/23	231.28KB	Share
KZA	Executive Leadership changes - Dr John Friend appointed CEO	PRICE SENSITIVE	01/05/23	120.26KB	Share
KZA	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	332.77KB	Share
KZA	Kazia regains compliance with Nasdaq minimum bid requirement		14/04/23	106.63KB	Share
KZA	Notification of cessation of securities - KZA		12/04/23	24.69KB	Share
KZA	Change in substantial holding		06/04/23	1.5MB	Share
KZA	Kazia presents new data at AACR Annual Meeting		04/04/23	173.16KB	Share
KZA	Change of Director's Interest Notice		21/03/23	312.82KB	Share
KZA	Change of Director's Interest Notice		17/03/23	294.82KB	Share
KZA	Notification of cessation of securities - KZA		08/03/23	24.67KB	Share
KZA	Clinical Collaboration for Phase II clinical study		07/03/23	160.64KB	Share
KZA	Change in substantial holding		07/03/23	1.55MB	Share
KZA	Change in substantial holding		06/03/23	148.69KB	Share
KZA	Change of Director's Interest Notices		06/03/23	444.7KB	Share
KZA	Notification regarding unquoted securities - KZA		06/03/23	29.01KB	Share
KZA	Cleansing Notice		03/03/23	131.87KB	Share
KZA	Application for quotation of securities - KZA		03/03/23	25.5KB	Share
KZA	Change in substantial holding		02/03/23	1.56MB	Share
KZA	Resignation and appointment of Company Secretary		28/02/23	151.11KB	Share
KZA	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/23	619.33KB	Share
KZA	Kazia result of Share Purchase Plan	PRICE SENSITIVE	28/02/23	167.59KB	Share
KZA	Cleansing notice		28/02/23	177.02KB	Share
KZA	Application for quotation of securities - KZA		28/02/23	25.69KB	Share
KZA	Results of EGM		24/02/23	196.2KB	Share
KZA	Details of Auditor Appointment/Resignation		24/02/23	157.39KB	Share
KZA	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	15/02/23	581.96KB	Share
KZA	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	448.31KB	Share
KZA	Substantial shareholder notice		24/01/23	171.53KB	Share
KZA	Kazia Share Purchase Plan		19/01/23	341.72KB	Share
KZA	Notice of Extraordinary General Meeting/Proxy Form		19/01/23	410.52KB	Share
KZA	Change in substantial holding		18/01/23	225.02KB	Share
KZA	Change in substantial holding		18/01/23	1.52MB	Share
KZA	Cleansing notice		17/01/23	176.79KB	Share
KZA	Cleansing notice		17/01/23	76.48KB	Share
KZA	Application for quotation of securities - KZA		17/01/23	25.9KB	Share
KZA	Application for quotation of securities - KZA		17/01/23	25.79KB	Share
KZA	Proposed issue of securities - KZA		17/01/23	27.62KB	Share
KZA	Proposed issue of securities - KZA		16/01/23	25.45KB	Share
KZA	Kazia raises $4.5m and launches share purchase plan	PRICE SENSITIVE	16/01/23	240.25KB	Share
KZA	Trading Halt	PRICE SENSITIVE	12/01/23	212.37KB	Share
KZA	Kazia pre-clinical collaboration with QIMR		15/12/22	177.47KB	Share
KZA	Kazia receives Nasdaq minimum bid notice		13/12/22	184.61KB	Share
KZA	EVT801 preclinical data published	PRICE SENSITIVE	01/12/22	229.77KB	Share
KZA	Kazia AGM results		16/11/22	479.98KB	Share
KZA	AGM materials		16/11/22	748.3KB	Share
KZA	Change in substantial holding		14/11/22	1.53MB	Share
KZA	Kazia presents to Bell Potter Healthcare Conference		09/11/22	1.25MB	Share
KZA	Kazia to present to SNO		09/11/22	156.31KB	Share
KZA	Change in substantial holding		07/11/22	1.6MB	Share
KZA	Cleansing notice		04/11/22	76.44KB	Share
KZA	Application for quotation of securities - KZA		04/11/22	25.89KB	Share
KZA	Withdrawal of resolution		03/11/22	150.9KB	Share

KZA Removal from Official List
15/11/23		87.34KB	Share
KZA Change in substantial holding
14/11/23		1.51MB	Share
KZA Suspension from Official List
13/11/23	PRICE SENSITIVE	86.69KB	Share
KZA Change in substantial holding
08/11/23		1.59MB	Share
KZA Notice of Annual General Meeting/Proxy Form
03/11/23		1.07MB	Share
KZA Preliminary update from ongoing Phase 2 Study of Paxalisib
02/11/23		150.76KB	Share
KZA Proposed issue of securities - KZA
31/10/23		24.89KB	Share
KZA Kazia announces short term unsecured Promissory Note
31/10/23	PRICE SENSITIVE	169.34KB	Share
KZA Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	253.76KB	Share
KZA Kazia SEC Form 20-F
27/10/23		630.23KB	Share
KZA Kazia announces Clinical Data at ESMO 2023 from EVT801 Study
24/10/23		167.72KB	Share
KZA Change in substantial holding
23/10/23		1.51MB	Share
KZA Change of AGM date
16/10/23		127.98KB	Share
KZA Shareholder communication on the ASX de-listing process
13/10/23	PRICE SENSITIVE	667.16KB	Share
KZA Reinstatement to Official Quotation
11/10/23	PRICE SENSITIVE	408.79KB	Share
KZA Kazia announces intention to voluntarily de-list from ASX
11/10/23	PRICE SENSITIVE	226.44KB	Share
KZA Voluntary Suspension
10/10/23	PRICE SENSITIVE	299.26KB	Share
KZA Trading Halt
06/10/23	PRICE SENSITIVE	1.03MB	Share
KZA Presentations at upcoming scientific meetings
05/10/23		128.19KB	Share
KZA Acceptance of late-breaking abstract of PNOC022 data
29/09/23	PRICE SENSITIVE	129.86KB	Share
KZA Change in substantial holding
11/09/23		1.52MB	Share
KZA 2023 Corporate Governance Statement
31/08/23		219.65KB	Share
KZA Appendix 4G
31/08/23		275.48KB	Share
KZA Appendix 4E and 2023 Annual Report
31/08/23	PRICE SENSITIVE	6.51MB	Share
KZA Final Director's Interest Notice - Iain Ross
11/08/23		231.26KB	Share
KZA Cleansing Notice - updated
11/08/23		131.48KB	Share
KZA Cleansing Notice
11/08/23		130.98KB	Share
KZA Application for quotation of securities - KZA
11/08/23		26.63KB	Share
KZA Kazia announces change to Board of Directors
11/08/23		125.76KB	Share
KZA Appointment of Dr John Friend as Managing Director
01/08/23		272.73KB	Share
KZA Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	318.42KB	Share
KZA Notification regarding unquoted securities - KZA
19/07/23		26.04KB	Share
KZA Change in substantial holding
17/07/23		210.33KB	Share
KZA Cleansing Notice
14/07/23		154.33KB	Share
KZA Appendix 2A
14/07/23		177.14KB	Share
KZA Proposed issue of securities - KZA
14/07/23		25.07KB	Share
KZA Notification of cessation of securities - KZA
13/07/23		22.53KB	Share
KZA Change in substantial holding
11/07/23		1.5MB	Share
KZA Paxalisib receives Fast Track Designation from US FDA
07/07/23		183.55KB	Share
KZA Kazia Corporate Update and Corporate Presentation
26/06/23		2.61MB	Share
KZA Launch of LUMOS2 Study
08/06/23		163.17KB	Share
KZA Constitution
07/06/23		493.48KB	Share
KZA Appointment of Non-executive Director
05/06/23		278.65KB	Share
KZA Kazia CEO participates in White House Cancer Moonshot Forum
26/05/23		138.12KB	Share
KZA Cancel - Notification of cessation of securities - KZA
25/05/23		24.21KB	Share
KZA Quarterly Activities/Appendix 4C Cash Flow Report - updated
09/05/23		410KB	Share
KZA Notification regarding unquoted securities - KZA
08/05/23		29.85KB	Share
KZA Notification of cessation of securities - KZA
05/05/23		24.66KB	Share
KZA Final Director's Interest Notice - Dr J Garner
02/05/23		231.28KB	Share
KZA Executive Leadership changes - Dr John Friend appointed CEO
01/05/23	PRICE SENSITIVE	120.26KB	Share
KZA Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	332.77KB	Share
KZA Kazia regains compliance with Nasdaq minimum bid requirement
14/04/23		106.63KB	Share
KZA Notification of cessation of securities - KZA
12/04/23		24.69KB	Share
KZA Change in substantial holding
06/04/23		1.5MB	Share
KZA Kazia presents new data at AACR Annual Meeting
04/04/23		173.16KB	Share
KZA Change of Director's Interest Notice
21/03/23		312.82KB	Share
KZA Change of Director's Interest Notice
17/03/23		294.82KB	Share
KZA Notification of cessation of securities - KZA
08/03/23		24.67KB	Share
KZA Clinical Collaboration for Phase II clinical study
07/03/23		160.64KB	Share
KZA Change in substantial holding
07/03/23		1.55MB	Share
KZA Change in substantial holding
06/03/23		148.69KB	Share
KZA Change of Director's Interest Notices
06/03/23		444.7KB	Share
KZA Notification regarding unquoted securities - KZA
06/03/23		29.01KB	Share
KZA Cleansing Notice
03/03/23		131.87KB	Share
KZA Application for quotation of securities - KZA
03/03/23		25.5KB	Share
KZA Change in substantial holding
02/03/23		1.56MB	Share
KZA Resignation and appointment of Company Secretary
28/02/23		151.11KB	Share
KZA Half Yearly Report and Accounts
28/02/23	PRICE SENSITIVE	619.33KB	Share
KZA Kazia result of Share Purchase Plan
28/02/23	PRICE SENSITIVE	167.59KB	Share
KZA Cleansing notice
28/02/23		177.02KB	Share
KZA Application for quotation of securities - KZA
28/02/23		25.69KB	Share
KZA Results of EGM
24/02/23		196.2KB	Share
KZA Details of Auditor Appointment/Resignation
24/02/23		157.39KB	Share
KZA Quarterly Activities/Appendix 4C Cash Flow Report
15/02/23	PRICE SENSITIVE	581.96KB	Share
KZA Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	448.31KB	Share
KZA Substantial shareholder notice
24/01/23		171.53KB	Share
KZA Kazia Share Purchase Plan
19/01/23		341.72KB	Share
KZA Notice of Extraordinary General Meeting/Proxy Form
19/01/23		410.52KB	Share
KZA Change in substantial holding
18/01/23		225.02KB	Share
KZA Change in substantial holding
18/01/23		1.52MB	Share
KZA Cleansing notice
17/01/23		176.79KB	Share
KZA Cleansing notice
17/01/23		76.48KB	Share
KZA Application for quotation of securities - KZA
17/01/23		25.9KB	Share
KZA Application for quotation of securities - KZA
17/01/23		25.79KB	Share
KZA Proposed issue of securities - KZA
17/01/23		27.62KB	Share
KZA Proposed issue of securities - KZA
16/01/23		25.45KB	Share
KZA Kazia raises $4.5m and launches share purchase plan
16/01/23	PRICE SENSITIVE	240.25KB	Share
KZA Trading Halt
12/01/23	PRICE SENSITIVE	212.37KB	Share
KZA Kazia pre-clinical collaboration with QIMR
15/12/22		177.47KB	Share
KZA Kazia receives Nasdaq minimum bid notice
13/12/22		184.61KB	Share
KZA EVT801 preclinical data published
01/12/22	PRICE SENSITIVE	229.77KB	Share
KZA Kazia AGM results
16/11/22		479.98KB	Share
KZA AGM materials
16/11/22		748.3KB	Share
KZA Change in substantial holding
14/11/22		1.53MB	Share
KZA Kazia presents to Bell Potter Healthcare Conference
09/11/22		1.25MB	Share
KZA Kazia to present to SNO
09/11/22		156.31KB	Share
KZA Change in substantial holding
07/11/22		1.6MB	Share
KZA Cleansing notice
04/11/22		76.44KB	Share
KZA Application for quotation of securities - KZA
04/11/22		25.89KB	Share
KZA Withdrawal of resolution
03/11/22		150.9KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

KAZIA THERAPEUTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available